summary
Introduced
03/08/2022
03/08/2022
In Committee
03/09/2022
03/09/2022
Crossed Over
Passed
Dead
01/03/2023
01/03/2023
Introduced Session
117th Congress
Bill Summary
A BILL To amend the Federal Food, Drug, and Cosmetic Act to authorize a program to support the adoption of, and improve the development of, innovative approaches to pharmaceutical product design and manufacturing, and for other purposes.
AI Summary
This bill, the Drug Manufacturing Innovation Act of 2022, would establish a program at the U.S. Food and Drug Administration (FDA) to support the adoption and development of innovative approaches to pharmaceutical product design and manufacturing. The program would facilitate communication, conduct research, provide education and training, and award grants to further the research and development of these innovative approaches. The bill also directs the FDA to issue or update guidance to help facilitate the adoption and advancement of innovative manufacturing technologies, including guidance on regulatory requirements and data needed for approval. The bill authorizes $20 million in funding per fiscal year from 2023 to 2027 to carry out these activities.
Committee Categories
Business and Industry, Health and Social Services
Sponsors (2)
Last Action
Referred to the Subcommittee on Health. (on 03/09/2022)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/117th-congress/house-bill/6988/all-info |
| BillText | https://www.congress.gov/117/bills/hr6988/BILLS-117hr6988ih.pdf |
| Bill | https://www.congress.gov/117/bills/hr6988/BILLS-117hr6988ih.pdf.pdf |
Loading...